Solaris Pharma Corporation is pleased to announce the product approval of Tazarotene Gel, 0.05% and 0.1%.
News &
Events
About Solaris
Solaris Pharma Corporation, A Privately Held Company Headquartered In Bridgewater, NJ, Is A Specialty Pharmaceutical Company Developing And Commercializing High Value Drug Products With Limited Generic Competitors. Solaris Is Committed To Development Of Complex Dosage Forms And 505(B)(2) Products That Bring Value To Patients By Providing Access To Quality, Affordable Medicine.
Contact
Shalin Jani
CEO
Info@Solaris-Pharma.com
Source: Solaris Pharma Corporation
Press Release
